STAA - CIK 0000718937
The table below shows STAAR SURGICAL CO's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$21.70M | -$5.73M | $21.68M | -$5.09M | -$4.61M | $6.77M |
| Capital expenditure | $443.00K | $1.47M | $5.20M | $2.90M | $2.54M | $2.16M |
| Investing cash flow | $2.15M | $35.35M | $16.19M | $9.93M | -$2.54M | -$2.16M |
| Dividends paid | - | - | - | - | - |
STAAR SURGICAL CO reported operating cash flow of -$34.23M for fiscal year 2026. That is down 317.7% from $15.72M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $1.05M (FY 2016) to -$34.23M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$1.69M | -$948.00K | $4.06M | -$1.36M | $894.00K | $6.00M |